US enacted tariffs on imports from Asia, impacting global supply chains and specific pharmaceutical companies.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
US enacted tariffs on imports from Asia, impacting global supply chains and specific pharmaceutical companies.
How it developed
Newest first. Tap a step to see who reported it.- Trump is using the threat of tariffs to encourage domestic manufacturing by pressuring pharma companies and leveraging the reliance on Indian and Chinese APIs.Sub-event
US tariffs on Asian imports affect global supply chains and pharma companies.1 source
Coverage
Newest first; wire copies grouped- NewMediaWireBioKey Stands as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts ABVC's 28,000 sq ft Silicon Valley Manufacturing Facility Stands Ready as Global Supply Chains Realign and Trust-ba